Risky Stem-Cell Treatments Come Under F.D.A. Scrutiny — Again
Warning that unapproved stem-cell treatments put patients at risk, the F.D.A. is notifying clinics and manufacturers that flout its rules.
from Health https://nyti.ms/2uKIHsy
from Health https://nyti.ms/2uKIHsy
No comments